Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial
Letter
[키워드] 24 hours
acute respiratory distress
administration
Admission
age
age and sex
allergy
ARDS
Arm
blinded
Blood oxygen saturation
can be used
checked
clinical
coded
Combination
combination regimen
Computed tomography
conducted
Contact
Control
control arm
Corticosteroid
Corticosteroids
COVID-19
COVID-19 patients
Critically ill
Critically ill patient
critically ill patients
Cytokine storm
develop
Dexamethasone
dissemination
dosage
dose
drug
early administration
education
Efficacy
element
eligible
excessive inflammatory response
experimental group
Frequency
generate
group
help
hepatitis B
HIV positive
hospital
Hospitalization
hospitalized patient
Hypothesis
Immunoglobulin
IMPROVE
increase in
Inflammation
information
Interferon-beta
Intervention
intervention group
Intravenous immunoglobulin
intubation
investigator
Iran
laboratory technician
less
lung
lung damage
management
mortality rate
MOST
number
Nurses
objective
outcome
Parallel Arm
participant
Patient
patients
Patients management
percentage
positive RT-PCR
Pregnancy
protocol
random
random number generator
randomised
randomised controlled trial
randomization
Randomized controlled trial
Randomly
RCT
receive
reduce
Registration
reported
researcher
respiratory rate
Sample size
severe COVID-19
Side effects
Standard
standard treatment
statistical
statistician
study drug
study group
Study protocol
subject
supportive care
syndrome
the cytokine storm
the WHO
treat
Treatment
Trial
website
WHO guideline
[DOI] 10.1186/s13063-020-04499-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04499-5 PMC 바로가기 [Article Type] Letter